Ray Amrit
SEC insider (Form 3/4/5 filer). CIK 0001924797. Director at Fortrea Holdings Inc. (FTRE) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in DURHAM, NC.
Companies Ray Amrit has filed insider reports for
- Fortrea Holdings Inc. (FTRE): Director
- Ultragenyx Pharmaceutical Inc. (RARE): Director
Ray Amrit
CIK: 0001924797
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 10, 2026FTRE
Fortrea Holdings Inc.
ExerciseDirect38.8K shares- - Jun 10, 2026FTRE
Fortrea Holdings Inc.
AwardDirectRestricted Stock Unit
12.9K shares- - May 14, 2026RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect7.8K shares- - Jun 10, 2025FTRE
Fortrea Holdings Inc.
AwardDirectRestricted Stock Unit
38.8K shares- - May 15, 2025RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect5.7K shares- - May 14, 2025FTRE
Fortrea Holdings Inc.
ExerciseDirect7.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  FTRE Fortrea Holdings Inc. | Exercise | 38,817 | - | $0 | Direct |
| Jun 10, 2026 | FTRE Fortrea Holdings Inc. | Award Restricted Stock Unit | 12,852 | - | - | Direct |
| May 14, 2026 |  RARE Ultragenyx Pharmaceutical Inc. | Award | 7,751 | - | $0 | Direct |
| Jun 10, 2025 | FTRE Fortrea Holdings Inc. | Award Restricted Stock Unit | 38,817 | - | - | Direct |
| May 15, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Award | 5,740 | - | - | Direct |
| May 14, 2025 | FTRE Fortrea Holdings Inc. | Exercise | 7,282 | - | - | Direct |
1-6 of 6 transactions